gsk: Britain’s GSK to buy Affinivax for up to $3.3 bln in vaccines push
GSK said on Tuesday it would pay up to $3.3 billion to acquire privately held biopharmaceutical firm Affinivax to bolster its vaccine pipeline, a key area of focus as the British…
Read More...
Read More...